Literature DB >> 18651664

Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.

Jessica L MacDonald1, A Jane Roskams.   

Abstract

The deacetylation of histone proteins, catalyzed by histone deacetylases (HDACs), is a common epigenetic modification of chromatin, associated with gene silencing. Although HDAC inhibitors are used clinically to treat nervous system disorders, such as epilepsy, very little is known about the expression pattern of the HDACs in the central nervous system. Identifying the cell types and developmental stages that express HDAC1 and HDAC2 within the brain is important for determining the therapeutic mode of action of HDAC inhibitors, and evaluating potential side effects. Here, we examined the expression of HDAC1 and HDAC2 in the murine brain at multiple developmental ages. HDAC1 is expressed in neural stem cells/progenitors and glia. In contrast, HDAC2 is initiated in neural progenitors and is up-regulated in post-mitotic neuroblasts and neurons, but not in fully differentiated glia. These results identify key developmental stages of HDAC expression and suggest transitions of neural development that may utilize HDAC1 and/or HDAC2. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651664     DOI: 10.1002/dvdy.21626

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  89 in total

1.  Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission.

Authors:  Erika D Nelson; Manjot Bal; Ege T Kavalali; Lisa M Monteggia
Journal:  J Neurophysiol       Date:  2011-04-20       Impact factor: 2.714

Review 2.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 3.  Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways.

Authors:  Antonella Riccio
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

4.  Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.

Authors:  Gregory C Sartor; Andrea M Malvezzi; Ashok Kumar; Nadja S Andrade; Hannah J Wiedner; Samantha J Vilca; Karolina J Janczura; Amir Bagheri; Hassan Al-Ali; Samuel K Powell; Peyton T Brown; Claude H Volmar; Thomas C Foster; Zane Zeier; Claes Wahlestedt
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

5.  Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue.

Authors:  Gavin Rumbaugh; Stephanie E Sillivan; Emin D Ozkan; Camilo S Rojas; Christopher R Hubbs; Massimiliano Aceti; Mark Kilgore; Shashi Kudugunti; Sathyanarayanan V Puthanveettil; J David Sweatt; James Rusche; Courtney A Miller
Journal:  Neuropsychopharmacology       Date:  2015-04-03       Impact factor: 7.853

6.  Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream.

Authors:  Yosuke Akiba; John W Cave; Nami Akiba; Brett Langley; Rajiv R Ratan; Harriet Baker
Journal:  Biochem Biophys Res Commun       Date:  2010-02-17       Impact factor: 3.575

7.  Expression of class I histone deacetylases during chick and mouse development.

Authors:  Christina Murko; Sabine Lagger; Marianne Steiner; Christian Seiser; Christian Schoefer; Oliver Pusch
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

8.  Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development.

Authors:  Rusty L Montgomery; Jenny Hsieh; Ana C Barbosa; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

9.  PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia.

Authors:  Tonya M Gilbert; Nicole R Zürcher; Christine J Wu; Anisha Bhanot; Baileigh G Hightower; Minhae Kim; Daniel S Albrecht; Hsiao-Ying Wey; Frederick A Schroeder; Anais Rodriguez-Thompson; Thomas M Morin; Kamber L Hart; Amelia M Pellegrini; Misha M Riley; Changning Wang; Steven M Stufflebeam; Stephen J Haggarty; Daphne J Holt; Marco L Loggia; Roy H Perlis; Hannah E Brown; Joshua L Roffman; Jacob M Hooker
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 10.  Epigenetic control of neurotransmitter expression in olfactory bulb interneurons.

Authors:  Kasturi Banerjee; Yosuke Akiba; Harriet Baker; John W Cave
Journal:  Int J Dev Neurosci       Date:  2012-12-03       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.